Dyadic Announces Continued Progress Towards Commercialization of Animal-Free Recombinant Serum Albumin
DYAI Stock | USD 1.70 0.01 0.58% |
Under 59% of Dyadic International's investor base is looking to short. The analysis of the overall investor sentiment regarding Dyadic International suggests that many traders are alarmed. Dyadic International's investing sentiment shows overall attitude of investors towards Dyadic International.
Dyadic |
JUPITER, Fla., Aug. 07, 2023 Dyadic International, Inc. , a global biotechnology company focused on building innovative microbial platforms to develop and manufacture biopharmaceuticals and alternative proteins for food, nutrition, health and wellness at flexible commercial scales affordably, today announced positive results from third party analytical testing of the companys animal-free recombinant serum albumin.
Read at finance.yahoo.com
Dyadic International Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Dyadic International can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Dyadic International Fundamental Analysis
We analyze Dyadic International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dyadic International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dyadic International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Insiders
Shares Owned By Insiders Comparative Analysis
Dyadic International is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Dyadic International Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dyadic International stock to make a market-neutral strategy. Peer analysis of Dyadic International could also be used in its relative valuation, which is a method of valuing Dyadic International by comparing valuation metrics with similar companies.
Peers
Dyadic International Related Equities
MNOV | MediciNova | 14.98 | ||||
HCWB | HCW Biologics | 8.51 | ||||
FBRX | Forte Biosciences | 8.06 | ||||
PMVP | Pmv Pharmaceuticals | 4.32 | ||||
ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
ELYM | Eliem Therapeutics | 0.31 | ||||
CELC | Celcuity LLC | 1.33 | ||||
HOWL | Werewolf Therapeutics | 2.00 | ||||
ANTX | AN2 Therapeutics | 4.19 | ||||
EWTX | Edgewise Therapeutics | 4.42 | ||||
CSBR | Champions Oncology | 4.65 | ||||
CCCC | C4 Therapeutics | 5.49 | ||||
DMAC | DiaMedica Therapeutics | 5.65 | ||||
MOLN | Molecular Partners | 7.22 |
Complementary Tools for Dyadic Stock analysis
When running Dyadic International's price analysis, check to measure Dyadic International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dyadic International is operating at the current time. Most of Dyadic International's value examination focuses on studying past and present price action to predict the probability of Dyadic International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dyadic International's price. Additionally, you may evaluate how the addition of Dyadic International to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |